Theramex - About the company
Theramex is an acquired company based in London (United Kingdom), founded in 1970. It operates as a Manufacturer of drugs for women's health. Theramex has raised an undisclosed amount in funding. The company has 39 active competitors, including 8 funded and 12 that have exited. Its top competitors include companies like Agile Therapeutics, Marius Pharmaceuticals and Peptonic Medical.
Company Details
Theramex is a specialty pharmaceutical company offering drugs for women's health. They provide their products in the field of contraception, fertility, menopause, and osteoporosis.
- Website
- www.theramex.com/
- Email ID
- *****@theramex.com
- Registered Address
- KANGA HEALTH LIMITED,1ST FLOOR, MEADOWSIDE,MOUNTBATTEN WAY,CONGLETON,CHESHIRE,UNITED KINGDOM,CW12 1DY
Key Metrics
Founded Year
1970
Location
London, United Kingdom
Stage
Acquired
Latest Funding Round
Investors
Ranked
10th among 39 active competitors
Employee Count
493 as on Oct 31, 2026
Similar Companies
Exit Details
Acquired by Cinven (Nov 05, 2026)
Legal entities associated with Theramex
Theramex is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
KANGA HEALTH LTD CIN: 8494015 , United Kingdom, Active | Apr 17, 2013 | - | 20 (As on Apr 30, 2024) |
Theramex's acquisition details
Click here to take a look at Theramex's acquisition in detail
Sign up to download Theramex's company profile
Theramex's funding and investors
Theramex has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Mar 01, 2021 for $*****. 1 investor participated in its latest round. Theramex has 2 institutional investors.
Here is the list of recent funding rounds of Theramex:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 01, 2021 | 3664880 | Grant (prize money) | 2540738 | 7790058 | 7611776 | 7193904 |
View details of Theramex's funding rounds and investors
Theramex's founders and board of directors
Founder? Claim ProfileTheramex's employee count trend
Theramex has 493 employees as of Oct 26. Here is Theramex's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Theramex's Competitors and alternates
Top competitors of Theramex include Agile Therapeutics, Marius Pharmaceuticals and Peptonic Medical. Here is the list of Top 10 competitors of Theramex, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Agile Therapeutics 1997, Princeton (United States), Acquired | Developer of therapeutics for women healthcare | $124M | 58/100 | |
2nd | Marius Pharmaceuticals 2017, Raleigh (United States), Series B | Developer of an proprietary oral testosterone replacement therapy platform | $32.6M | 48/100 | |
3rd | Peptonic Medical 2009, Vaxjo (Sweden), Public | Developer of therapeutics for the treatment of vaginal atrophy | $1.06M | 46/100 | |
4th | Auxilium Pharmaceuticals 1999, Philadelphia (United States), Acquired | Developer of therapeutics and drug-device combinations for urology and sexual health | $43M | 45/100 | |
5th | Creative Medical Technologies 2011, Phoenix (United States), Public | Stem-cell based therapeutics for male and female reproductive health | - | - | 43/100 |
6th | Microchips Biotech 1999, Lexington (United States), Acquired | Microchip-based implants for drug delivery | $90.7M | 42/100 | |
7th | Asarina Pharma 2006, Umea (Sweden), Series A | Developer of drugs for the premenstrual dysphoric disorder (PMDD) | $28M | 40/100 | |
8th | Xanodyne Pharmaceuticals 2001, Florence (United States), Acqui-Hired | Developer of drugs for women's health and pain management | $214M | 38/100 | |
9th | Prescient Therapeutics 1986, South Melbourne (Australia), Public | Targeted small molecule inhibitors of Ras and Akt pathway for the treatment of cancer | $3M | - | 38/100 |
10th | Theramex 1970, London (United Kingdom), Acquired | Manufacturer of drugs for women's health | - | 50/100 |
Looking for more details on Theramex's competitors? Click here to see the top ones
Theramex's Investments and acquisitions
Theramex has made no investments or acquisitions yet.
Reports related to Theramex
Here is the latest report on Theramex's sector:
News related to Theramex
Media has covered Theramex for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
•
•
Eladynos Receives Recommendation for Osteoporosis Treatment in Scottish NHSPharmaTimes•Jul 07, 2025•Theramex
•
Daré & Theramex partner to develop a biodegradable long-acting contraceptive implant.GlobeNewswire•Feb 20, 2025•Daré Bioscience, Theramex
•
Menopause, Theramex completes acquisition and expands offeringFarmacista33•Oct 02, 2024•Theramex, Viatris
•
Pharma, Theramex completes two acquisitions from Viatris in EuropeDealflower•Oct 02, 2024•Theramex, Viatris
•
•
Theramex gains European rights to Duphaston and Femoston from ViatrisPharmaceutical Technology•Oct 10, 2023•Theramex, Viatris
•
•
Are you a Founder ?
FAQs about Theramex
Explore our recently published companies
- Matador Gmbh - Unfunded company
- Nance & Associates - Fredericksburg based, Unfunded company
- Mi Facturacion - Mexico based, Unfunded company
- Medicine of Love - Unfunded company
- Vom Dreieck - Unfunded company
- The Dancing Pirate - Netherlands based, 2026 founded, Unfunded company
